Related Experiment Video
Updated: Jan 11, 2026

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica
Published on: October 28, 2022
ML385 Attenuates Malignant Progression of Silica-induced Lung Adenocarcinoma Cells through the ROS/NRF2-autophagy
Yanhong Cao1, Wubi Zhou2, Junwen Cai3
1School of Medicine, Anhui University of Science and Technology; Department of Medical Laboratory, Huaian Hospital of Huaian City.
Abstract:
Silica exposure is associated with an increased risk of lung adenocarcinoma, but its molecular mechanism remains unclear. This study aims to establish a repeatable experimental protocol to explore how the nuclear factor erythroid 2-related factor 2 (NRF2) inhibitor ML385 inhibits silica-induced malignant progression of lung adenocarcinoma by regulating the ROS/NRF2-autophagy axis pathway. Firstly, a silicosis model was established by intranasal perfusion of silica suspension in C57BL/6 mice. The degree of pulmonary fibrosis was evaluated by Masson staining, the infiltration of immune cells was analyzed by immunofluorescence, and the expressions of NRF2, cyclin-dependent kinase 1 (CDK1), and voltage-dependent anion channel 1 (VDAC1) in lung tissue were detected by immunohistochemistry. Subsequently, in in vitro experiments, the RAW264.7 macrophage cell line was treated with silica. Autophagic flux and oxidative stress levels were evaluated by LC3-lysosome co-localization and ROS probes, and intervention was carried out with the NRF2 inhibitor ML385. Finally, the effects of ML38 on migration, invasion, and apoptosis of lung adenocarcinoma cells were analyzed by scratch assay, cells passing through pores of a specific size assay, and flow cytometry. The results showed that silica could induce pulmonary fibrosis, immune cell infiltration, and upregulation of NRF2, CDK1, and VDAC1 in mice (p < 0.001), and inhibit the autophagic flux of macrophages and reduce ROS levels. ML385 can reverse these effects (p < 0.05). This protocol provides a complete experimental process from in vivo model construction to in vitro mechanism research, offering an operational technical path for studying the molecular mechanism of silica-related lung adenocarcinoma and therapeutic strategies targeting NRF2.
Insights
Silica exposure promotes lung adenocarcinoma by affecting NRF2 and autophagy. The NRF2 inhibitor ML385 reverses these malignant changes, offering a potential therapeutic strategy for silica-related lung cancer.
Area of Science:
- * Environmental Health
- * Molecular Biology
- * Cancer Research
Background:
- * Silica exposure is linked to lung adenocarcinoma, but the underlying molecular mechanisms are not fully understood.
- * The nuclear factor erythroid 2-related factor 2 (NRF2) pathway and autophagy are implicated in cancer progression and response to environmental toxins.
- * Understanding these pathways is crucial for developing targeted therapies against silica-induced lung cancer.
Purpose of the Study:
- * To establish a repeatable experimental protocol for investigating silica-induced lung adenocarcinoma.
- * To explore the inhibitory effect of the NRF2 inhibitor ML385 on malignant progression.
- * To elucidate the role of the ROS/NRF2-autophagy axis in silica-induced lung cancer.
Main Methods:
- * Establishment of a silicosis mouse model via intranasal silica perfusion.
- * In vitro studies using RAW264.7 macrophages treated with silica and ML385.
- * Analysis of pulmonary fibrosis, immune cell infiltration, protein expression (NRF2, CDK1, VDAC1), autophagic flux, ROS levels, and lung adenocarcinoma cell migration, invasion, and apoptosis.
Main Results:
- * Silica induced pulmonary fibrosis, immune cell infiltration, and upregulated NRF2, CDK1, and VDAC1 in mice.
- * Silica inhibited macrophage autophagic flux and reduced ROS levels.
- * ML385 treatment reversed silica-induced changes, inhibiting malignant progression in lung adenocarcinoma cells.
Conclusions:
- * The established protocol provides a comprehensive approach for studying silica-related lung adenocarcinoma.
- * The ROS/NRF2-autophagy axis is a key pathway in silica-induced lung cancer progression.
- * ML385 demonstrates potential as a therapeutic agent targeting NRF2 for silica-induced lung adenocarcinoma.
More Related Videos
06:12Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...